Screen4Care has launched a recruitment for newborn screening in Ferrara, Italy and in Dijon, France – the conditions include MLD, CTX, Krabbe, Leigh syndrome. The Screen4Care project is an innovative research initiative by a European consortium, led by the University of Ferrara and Pfizer, aimed at improving the early diagnosis of rare genetic diseases in newborns.
To find out more about the project: Screen4Care NBS
An article published in May discusses the inclusive selection process of genes which will be used in the project called the ‘TREAT-panel’.
To read the article: TREAT: selection process for Screen4Care project
